Is Suzan Kereere’s 3M (MMM) Form 4 transaction mainly compensation-related?

Yes. The transaction is coded as a grant or award, and the footnote links part of the position to deferred dividend reinvestment under a director compensation plan. Together, these details indicate compensation-driven share accumulation rather than open-market buying or selling activity.

3M director granted 1,360 shares in stock award

3M director Suzan Kereere received a stock grant of 1,360.402 shares of 3M common stock at $143.34 per share.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

3M director Suzan Kereere received a stock grant of 1,360.402 shares of 3M common stock at $143.34 per share. This compensation-related award increased her direct holdings to 6,422.491 shares. A separate entry reports 1,740.410 shares held indirectly by a corporation.

According to a footnote, the reported holdings include acquisition of deferred dividend reinvestment shares under 3M's Compensation Plan for Non-Employee Directors, indicating the transactions are tied to director compensation and plan features rather than open-market trades.

Insider Trade Summary

Grant/Award: 1,360.402 shares

Grant/Award 2 txns

Insider Kereere Suzan

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,360.402	$143.34	$195K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 6,422.491 shares (Direct); Common Stock — 1,740.41 shares (Indirect, By Corporation)

Footnotes (1)

F1. Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors.

Key Figures

Stock grant size: 1,360.402 shares Grant price: $143.34 per share Direct holdings after grant: 6,422.491 shares +1 more

4 metrics

Stock grant size 1,360.402 shares Common stock grant on May 12, 2026

Grant price $143.34 per share Value assigned to common stock award

Direct holdings after grant 6,422.491 shares Common stock directly owned following transaction

Indirect holdings 1,740.410 shares Common stock held indirectly by a corporation

Key Terms

Grant, award, or other acquisition, deferred dividend reinvestment shares, Compensation Plan for Non-Employee Directors, indirect ownership

4 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

deferred dividend reinvestment shares financial

"Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan"

Compensation Plan for Non-Employee Directors financial

"pursuant to 3M's Compensation Plan for Non-Employee Directors"

indirect ownership financial

"total_shares_following_transaction 1740.4100, ownership_type: indirect, nature_of_ownership: By Corporation"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did 3M (MMM) director Suzan Kereere report in this Form 4?

Suzan Kereere reported receiving a grant of 1,360.402 shares of 3M common stock at $143.34 per share. The filing also shows updated direct holdings of 6,422.491 shares and a separate indirect position of 1,740.410 shares held by a corporation.

Was Suzan Kereere’s 3M (MMM) transaction an open-market purchase or sale?

The Form 4 shows a grant classified as a “Grant, award, or other acquisition,” not an open-market trade. The shares were received as part of compensation, including deferred dividend reinvestment shares under 3M’s Compensation Plan for Non-Employee Directors.

How many 3M (MMM) shares does Suzan Kereere hold after this grant?

After the grant, Suzan Kereere directly holds 6,422.491 shares of 3M common stock. The filing also lists 1,740.410 additional shares held indirectly by a corporation, reflecting total reported exposure split between direct and indirect ownership.

What price is associated with Suzan Kereere’s 3M (MMM) stock grant?

The reported grant price is $143.34 per share for 1,360.402 shares of 3M common stock. This price is used to value the compensation-related award recorded in the Form 4 and does not indicate an open-market purchase transaction.

What does the footnote about deferred dividend reinvestment shares for 3M (MMM) mean?

The footnote explains that reported holdings include deferred dividend reinvestment shares acquired under 3M’s Compensation Plan for Non-Employee Directors. This indicates some shares were accumulated automatically through the plan rather than through discretionary market trades.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/13/2026 - 04:21 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kereere Suzan

(Last)

(First)

(Middle)

3M CENTER

(Street)

ST. PAUL

MINNESOTA

55144

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
3M CO [ MMM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/12/2026		A		1,360.402	A	$143.34	6,422.491	D
Common Stock								1,740.41⁽¹⁾	I	By Corporation

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors.

	/s/ Patricia L. Meagher, attorney-in-fact for Suzan B. Kereere	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR